Slideshow

Focus on Bipolar Disorder: 6 New Studies

Author(s):

Leo Robert

Treatment failure risk is high, new biomarker of conversion from major depressive disorder, depression stifles creativity, and other recent findings are summarized here.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!
Related Videos
medication switching bipolar disorder
lithium
Related Content
risperidone injection FDA approval
September 9th 2025

FDA Approves Risperidone Extended-Release Injectable Suspension

Jessica Walters
Blue Light, Depression, and Bipolar Disorder
September 9th 2025

Blue Light, Depression, and Bipolar Disorder

Chris Aiken, MD Kellie Newsome, PMH-NP
bipolar
September 9th 2025

Primary End Point of Phase 3 Trial Met: BXCL501 for Agitation Associated With Bipolar Disorders or Schizophrenia

Leah Kuntz
Four Myths About Lamotrigine
September 9th 2025

Four Myths About Lamotrigine

Chris Aiken, MD Kellie Newsome, PMH-NP
hepatitis-c schizophrenia bipolar
September 9th 2025

Hepatitis-C Virus Found to Be Associated With Schizophrenia and Bipolar Disorder

Jessica Walters
bipolar
September 9th 2025

BXCL501 for Agitation Associated With Bipolar Disorders or Schizophrenia: Positive Pre-sNDA Meeting With FDA

Leah Kuntz
© 2025 MJH Life Sciences

All rights reserved.